Why the study?
Does O reduce blood pressure more effectively than V, L, or placebo in mild-to-moderate hypertensive patients?
Does O reduce blood pressure more effectively than V, L, or placebo in mild-to-moderate hypertensive patients?
Treatment with O 40mg daily resulted in greater blood pressure reductions and higher goal achievement rates at 8 weeks compared to L and placebo.
Answers are grounded in this paper and cite their sources.
O 40 mg yields greater SeDBP reduction than L or placebo; extends comparative ARB efficacy data in mild-moderate hypertension.
were titrated to once daily O 40mg, V 160mg and L 100mg.At wk 8, pts taking O remained at 40mg daily (maximum recommended dose) for an additional 4 wks, pts taking V were titrated to 320mg daily, and pts taking L were titrated to 50mg twice daily.The primary endpoint was mean change in cuff seated diastolic BP (SeDBP) from baseline to wk 8. Secondary efficacy variables included mean change in cuff seated systolic BP (SeSBP).A secondary analysis was performed to determine BP goal rates.Wk 12 analysis was designed to show equivalence of treatments.BPs were measured 21-27 h post-dose (trough).Daily administration of O 40mg, V 160mg or L 100mg significantly reduced mean SeDBP and SeSBP from baseline (P0.001) and versus PLA (P0.01) at wk 8.For the primary endpoint, mean reduction in SeDBP with O (-13.1 mmHg) was greater than L (-9.6 mmHg; P0.001) and PLA (-6.8 mmHg; P0.001) and numerically greater than V (-11.8 mmHg; P0.078, NS).Mean reduction in SeSBP with O (-15.1 mmHg) was also greater than L (-11.0 mmHg; P0.001) and PLA (-6.2 mmHg; P0.001) and numerically greater than V (-12.8 mmHg; P0.054, NS).The BP differences allowed forty percent more pts to achieve BP 140/90 mmHg with O compared with V (40.3% vs 28.5%; P0.016), and twice as many to achieve this goal with O compared with L (40.3% vs 20.1%; P0.001) at wk 8. PLA allowed 12.2% of pts to achieve this goal.At 12 wks (maximum recommended doses), mean reductions in SeSBP and SeDBP were similar for each active treatment arm.However, the percentage of pts achieving BP 130/85 mmHg with O was numerically greater than V (18.0%vs 10.9%; P0.057, NS) and L (18.0% vs 11.2%; P0.069, NS) and significantly greater than PLA (18.0%vs 2.3%; P0.001).Thus, O is an effective antihypertensive agent and allowed more pts to achieve BP goals compared with V and L at wk 8.
No takes yet. Share an insight, caveat, or question.
Gosse et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: